NTRK fusion positive colorectal cancer as a unique subset of CRC with high tumor mutation burden and microsatellite instability. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I.

New tool supports discovery of differentially methylated regions and epigenetic target identification for cancer metastasis and human development research Human methylome panel facilitates development ...

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of the ...

GUANGZHOU, China, Oct. 11, 2021 /PRNewswire/ -- The Twist Alliance Pan-Cancer Methylation Panel (Pan-Cancer Panel), a solution for pan-cancer study including DNA methylation library preparation and ...

Predicting overall survival (OS) in patients (pts) with penile squamous cell carcinoma (PSCC) undergoing regional lymph node dissection (LND) ± multimodal therapy. This is an ASCO Meeting Abstract ...

The methylome plays an important role in a wide range or physiological processes, including in cancer, where certain epigenetic changes can drive disease. Scientists can sequence cell-free DNA (cfDNA) ...

The researchers measured the variation in DNA methylation patterns to develop the method and applied it to multiple types of cancer.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...